Skip to search.
 FTSE 100 Down 1.43%

Kite Pharma, Inc. (KITE)

-NasdaqGS
65.31 Up 0.24(0.37%) 6 Jul 21:00
|After Hours: : 65.40 Up 0.09 (0.14%) 7 Jul 00:55
Add to Portfolio
Prev Close:65.07
Open:64.19
Bid:65.40 x 300
Ask:67.85 x 100
1y Target Est:84.33
Beta:N/A
Next Earnings Date:N/A
Day's Range:63.50 - 66.70
52wk Range:21.00 - 89.21
Volume:1,326,754
Avg Vol (3m):1,275,100
Market Cap:2.81b
P/E (ttm):N/A
EPS (ttm):-1.72
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
KITEUp 0.37%2.81b
CELGDown 0.59%94.24b
NVSDown 1.18%238.69b
PFEDown 0.36%204.74b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):972.53
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-1.69
Quarterly EPS Est (Jun-15) :-0.40
Mean Recommendation*:1.4
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Kite Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel cancer immunotherapy products. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback